Markets

LogicBio Therapeutics Granted FDA Orphan Drug Designation for LB-001 to Treat Methylmalonic Acidemia

LogicBio Therapeutics Granted FDA Orphan Drug Designation for LB-001 to Treat Methylmalonic Acidemia

LogicBio Therapeutics, Inc. (LOGC), a genome editing company, reported that the US Food and Drug Administration (FDA) has granted orphan drug designation to LB-001, a recombinant adeno-associated viral vector with human methylmalonyl-COA mutase (MUT) gene for the treatment of methylmalonic acidemia (MMA). “We believe that LB-001 has potential to transform the treatment of this devastating disease,” said Chief Executive Fred […]

S&P 500’s Q1 Results So Far Show More EPS Beats Than Revenue Beats

S&P 500’s Q1 Results So Far Show More EPS Beats Than Revenue Beats

The Standard & Poor’s 500 index has seen higher-than-expected Q1 earnings per share from 58 of the 77 companies that have released full operating comparative quarterly data as of Friday, according to a report from Howard Silverblatt, senior index analyst at S&P Dow Jones Indices. While that amounts to an EPS beat rate of 75% so far, there haven’t been […]